ABSTRACT:
Diabetic Neuropathic (DN) disorders are emerges in the peripheral nerve system's somatic and autonomic parts. A number of organs are connected by motor, sensory, and vasomotor fibers that are impacted by Diabetic Autonomic Neuropathy (DAN). As a result, DAN may impact several organ systems, including the Gastrointestinal, Cardiovascular, and Genitourinary. The pathophysiology of DN encompasses protein kinase C activation, polyol pathway flux, oxidative stress, and advanced end products of glycation, all of which lead to microvascular conditions and nerve damage. Poorly understood and underappreciated, treatment-induced neuropathy due to diabetes is an iatrogenic consequence of stringent glucose control in diabetics. Diabetic neuropathy has now few effective treatments options. Researching safe and effective medications to treat metabolic disorders is crucial since phytopharmaceuticals are well-known as having important roles in medicine. Finally, this review article can encourage physicians and researchers to do well-studied research to find a new therapy and management to improve metabolic control with DAN disorder; hence this study may be proven to be effective for DAN patients.
Cite this article:
Nikita Singh, Ankita Kumari, Ladli Kishore. New-insight Management Implications of Diabetic Autonomic Neuropathy: Future Perspectives. IJRPAS, Nov-Dec 2024; 3(6): 63-71.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2025.4106
- Kumari L, Mazumder
PM, Lal UR. Activity of Proline and its analogs isolated from Murraya koenigii against
hyperglycemia, oxidative stress and renal insufficiency in diabetic
nephropathy. Int J Pharmacog
Phyto Res. 2016; 8(1): 71-79.
- Kishore L. Clinical
Evaluation of Diabetic Complication: Nephropathy. Book Recent advances in
Pharmaceutical Sciences. Akinik Publishers. Editor: Dr. Chhavi Singla;
2021, Volume 6th, chapter 7th, Page no 113-125. ISBN: 978-93-91538-19-4.
- World Health Organization. Diabetes. 2025.
- World Health Organization. Health in Diabetes. 2025.
- Kishore
L and Mazumder PM. Extraction and evalution of Trigonella foenum-graecum L. seed extract for attenuating
the progression of nephropathy in diabetic rat. As J Pharmacy Pharmacol.
2019; 5(5), 933-941.
- Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic
neuropathy. Nat Rev Dis
Primers. 2019; 5: 41.
- Saul
G. Insights from the diabetes control and complications trial/epidemiology
of diabetes interventions and complications study on the use of intensive
glycemic treatment to reduce the risk of complications of type 1 diabetes.
Endocr Pract. 2006; 12 Suppl 1: 34-41.
- National
Institute of Diabetes and Digestive and Kidney Diseases, 2025.
- Kishore L,
Sharma A, Tripathi AS. Epilepsy: Exploring a review of a descriptive
study of epidemiology focuses on its measures, data sources, and analysis
the global burden of disease from 2010 to 2019 before the onset of the
COVID-19 pandemic. Int J Pharma Bio sci. Jan 2025; 16 (1):1-12.
- Vinik AI, Raelene E, Maser, et al. Diabetic Autonomic
Neuropathy. Diabetes Care. 2003; 26(5):1553-1579.
- Maser RE, Lenhard MJ, DeCherney GS: Cardiovascular
autonomic neuropathy: the clinical significance of its
determination. Endocrinologist. 2000; 10, 27-33.
- Schumer MP, Joyner SA, Pfeifer MA: Cardiovascular
autonomic neuropathy testing in patients with diabetes. Diabetes
Spectrum, 11, 227–231, 1998.
- Sharma N, Mehenditra H,
Singh S, et al. Elucidating the Role of Transferosomes as a
Promising Platform for Management of Various Types of Arthritis: A
Comprehensive Review". BioNanoScience. 2025, 15-56.
- Aaron V, Raelene EM, Braxton D, et al.
Diabetic autonomic neuropathy. Diabetes Care. 2003 May; 26(5):1553-1579.
- Rosenberger DC, Blechschmidt V, Timmerman H, et al.
Challenges of neuropathic pain: focus on diabetic neuropathy. J
Neural Transm (Vienna). 2020; 127(4):589-624.
- Cernea S, Raz I. Management of diabetic nephropathy,
Metabolism. 2021; 123:154867.
- Kishore L and Mehta A. Assessing
guidelines for diabetes management in hypertension. Int J Pharmacog Pharm Res. 2024; 6(2): 32-36.
- Kumari L, Mazumder PM, Lal UR. High performance thin layer
chromatography fingerprint profile, isolation, its antioxidant activity
and spectroscopic characterization of marker compound of Murraya
koenigii. J Pharmacog Phyto. 2014; 3(4): 86-92.
- Peter
J Oates. Polyol pathway and diabetic peripheral neuropathy. Int Rev
Neurobiol, 2002:50: 325-392.
- Peter
J Oates . Aldose reductase, still a compelling target for diabetic
neuropathy.
Curr Drug Targets. 2008; 9(1):14-36.
- Roikjer
J, Morch CD, Ejskjaer N. Diabetic Peripheral Neuropathy: Diagnosis
and Treatment. Curr Drug Saf. 2021;16(1):2-16.
- Kishore
L. Review on arginine vasopressin deficiency and its resistance: A
disorder in children. IntJ Pharmacogno Clin Res. 2024; 6(2): 68-71.
- Patel
K, Horak H, Tiryaki E. Diabetic neuropathies. Muscle Nerve. 2021; 63(1):22-30.
- Sharma
JK, Rohatgi A, Sharma D. Diabetic autonomic neuropathy: a
clinical update. J R Coll Physicians Edinb. 2020 Sep; 50(3):269-273..
- Gibbons
CH. Treatment induced neuropathy of diabetes. Auton
Neurosci. 2020; 226:102668.
- Kishore
L. Natural Remedies: For Gastroesophageal Reflux Disease. J Med Plants
studies. 2021; 9(4): 114-118.
- Saraswat
N , Sachan N , Chandra P.Anti-diabetic, diabetic
neuropathy protective action and mechanism of action involving oxidative
pathway of chlorogenic acid isolated from Selinum vaginatum roots in rats. Heliyon. 2020; 6(10), 05137.
- Balodi
KN, Purohit MV, Shridhar V, Arunachalam K. Ethno-medicinal uses
of various plants species among the Jaad Bhotiya community of Uttarakhand,
Western Himalaya. Ethno Med. 2018; 18:189-197.
- Addepalli
V, Suryavanshi SV. Catechin attenuates diabetic autonomic neuropathy
in streptozotocin induced diabetic rats. Biomed Pharmacother. 2018; 108: 1517-1523.
- Dewanjee
S, Chakraborty P, Mukherjee B, De Feo V. Plant-based antidiabetic
nanoformulations: The Emerging Paradigm for Effective Therapy. Int J Mol
Sci. 2020 Mar 23;21(6):2217.
- Ladli
Kishore. Finger print analysis by HPTLC, isolation, evaluation of its
in-vitro antioxidant activity and spectroscopic characterization of
bioactive compounds of Trigonella foenum-graecum seeds. Int J Pharmacogno Phyto Res, (2019); 11(2):
53-59.
- Moghadam
FH, Vakili Zarcg B, Shafiee M, et al. Fenugreek seed extract treats
peripheral neuropathy in pyridoxine induced neuropathic mice. Exp clin sci
J. 2013; 25(12):282-290
- Hong BN, Yi
TH, Kim SY, Kang TH. High-dosage pyridoxine-induced auditory
neuropathy and protection with coffee in mice. Biol Pharm Bull. 2009;32(4):597-603.
- Kumari
L and Mazumder PM. HPTLC finger printing profile and evaluation of
in-vitro antioxidant activity of extracts from seeds of Trigonella foneum graecum Linn in
different solvents. Int J of Res Pharma Bio Sci. 2013; 4 (2): 417-427.
- Marin-Penalver JJ, Martin-Timon I,
Collantes CS, et al. Update on the treatment of type 2 diabetes mellitus. W
J Dia. 2016; 7(17):354-395.
- Nauck
MA, Meininger G, Sheng D, et al. Efficacy and safety of the dipeptidyl
peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea,
glipizide, in patients with type 2 diabetes inadequately controlled on
metformin alone: a randomized, double-blind, non-inferiority trial. Dia
Obes Metab. 2007; 9:194-205.
- Mehendiratta H, Singh S, Sharma N, et al. Advances in
liposomes-based-therapeutics as a cutting-edge for ocular fungal infections:
An updated review. BioNanoScience. 2024; 14:3522-3535,
- Bosi
E, Camisasca RP, Collober C, Rochotte E, Garber AJ. Effects of
vildagliptin on glucose control over 24 weeks in patients with type 2
diabetes inadequately controlled with metformin. Dia Care. 2007; 30:890-895.
- Rosenstock
J, Sankoh S, List JF. Glucose-lowering activity of the dipeptidyl
peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2
diabetes. Dia Obes Metab. 2008;10:376-386.
- Shahare
PM, Wal A, Dwivedi SK, et al. Intellectual Property India, Design application
no: 417717-001. Apparatus for estimation of nerve damage in diabetic
neuropathy, May 2024.
- Syed
AA, Kumar S, Devi J, et al. Intellectual Property UK, Portable device for
bone cancer detection, Application no: 6333718, Granted: 3rd
Jan 2024,.